Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tandem Diabetes Care, Inc. - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
TNDM
Nasdaq
3850
www.tandemdiabetes.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tandem Diabetes Care, Inc.
3 Healthcare Stocks with Questionable Fundamentals
- Jul 23rd, 2026 3:58 am
1 Unprofitable Stock with Exciting Potential and 2 Facing Challenges
- Jul 17th, 2026 7:05 am
Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks
- Jul 16th, 2026 1:05 pm
Does Libre 3 Plus Integration Expand Tandem’s Interoperability Edge And Bull Case For TNDM?
- Jul 11th, 2026 7:07 pm
Is Tandem Diabetes Care (TNDM) Undervalued Following Its Abbott Libre 3 Plus Expansion?
- Jul 11th, 2026 3:09 am
DXCM Grew. The Stock Did Not. Someone Is Wrong
- Jul 10th, 2026 6:08 am
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Turn Down
- Jul 9th, 2026 7:09 am
Is Abbott Laboratories (ABT) Stock Still a Healthcare Growth Opportunity After Analyst Target Cut?
- Jul 8th, 2026 8:49 am
Does TNDM Stock Still Deserve a Place in Your Portfolio?
- Jul 7th, 2026 7:56 am
Is the Market Underestimating Tandem Diabetes Care, Inc. (TNDM)’s Transition Risks?
- Jul 6th, 2026 11:53 pm
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets
- Jul 1st, 2026 6:30 am
Why Tandem Diabetes (TNDM) Shares Are Sliding Today
- Jun 30th, 2026 5:39 pm
Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026
- Jun 30th, 2026 6:30 am
1 Mooning Stock with Impressive Fundamentals and 2 We Find Risky
- Jun 19th, 2026 6:04 am
Tandem Diabetes (TNDM): Buy, Sell, or Hold Post Q1 Earnings?
- Jun 16th, 2026 7:37 am
NeuroPace (NPCE) Down 0.6% Since Last Earnings Report: Can It Rebound?
- Jun 11th, 2026 9:30 am
How The Investment Story For Tandem Diabetes Care (TNDM) Is Evolving Without New Analyst Targets
- Jun 7th, 2026 5:07 pm
Wall Street Analysts See a 56.2% Upside in Tandem Diabetes Care (TNDM): Can the Stock Really Move This High?
- Jun 5th, 2026 7:55 am
Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy
- Jun 5th, 2026 6:30 am
Zacks.com featured highlights include Tandem, Dell and CNO Financial
- Jun 5th, 2026 2:50 am
Scroll